Jeffrey Scott Riley - Mar 28, 2024 Form 4 Insider Report for Gain Therapeutics, Inc. (GANX)

Role
Director
Signature
/s/ Jeffrey Scott Riley
Stock symbol
GANX
Transactions as of
Mar 28, 2024
Transactions value $
$115,770
Form type
4
Date filed
4/1/2024, 04:01 PM
Previous filing
Jun 26, 2023
Next filing
Jun 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GANX Common Stock Purchase $116K +30K $3.86 30K Mar 28, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7098 to $3.924, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.